×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Aldeyra's Eye Drug Meets Main Goal in Study, Shares Surge
Yahoo Movies UK
Aldeyra (ALDX) announced positive top-line data from a phase III study on pipeline product, reproxalap topical ophthalmic solution in...
2 days ago
FDA rejects Aldeyra's dry eye drug, asks for more clinical data
Clinical Trials Arena
FDA rejects Aldeyra's dry eye drug, asks for more clinical data. Aldeyra has submitted new trial plans to the FDA with anticipated NDA...
5 months ago
ALDX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Aldeyra ...
ConchoValleyHomepage.com
NEW YORK, NY / ACCESSWIRE / August 18, 2023 / The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of...
1 day ago
Aldeyra plans new drug application resubmission for reproxalap
Healio
Nearly 5 months after the FDA did not approve reproxalap for dry eye, Aldeyra Therapeutics has announced a plan to resubmit a new drug...
1 month ago
ADC Tx, Aldeyra leave programs behind in 2023
Fierce Biotech
For ADC Therapeutics and Aldeyra, ringing in the new year means leaving certain programs behind in 2023.
4 months ago
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis ...
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial...
1 week ago
FDA Rejects Aldeyra’s Dry Eye Drug, Cites Need for Additional Trial
BioSpace
FDA Rejects Aldeyra's Dry Eye Drug, Cites Need for Additional Trial ... The FDA on Monday rejected Aldeyra Therapeutics' investigational reactive...
5 months ago
ALDX Stock Earnings: Aldeyra Therapeutics Meets EPS for Q1 2024
MSN
ALDX stock results show that Aldeyra Therapeutics met analyst estimates for earnings per share the first quarter of 2024.More From InvestorPlace The #1 AI...
2 days ago
Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
Yahoo Finance
Here is how Aldeyra Therapeutics, Inc. (ALDX) and Inspire Medical Systems (INSP) have performed compared to their sector so far this year.
2 weeks ago
Milestone resubmits new drug application while Aldeyra readies similar 2nd-chance filing
Fierce Biotech
Milestone Pharmaceuticals has resubmitted a new drug application to the FDA, with Aldeyra readying a similar ask for the second half of the...
1 month ago